IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i16p8655-d615513.html
   My bibliography  Save this article

Colorectal Cancer Risk in Patients with Hemorrhoids: A 10-Year Population-Based Retrospective Cohort Study

Author

Listed:
  • En-Bo Wu

    (Department of Anesthesiology, China Medical University Hospital, China Medical University, Taichung 404, Taiwan)

  • Fung-Chang Sung

    (Department of Health Services Administration, College of Public Health, China Medical University, Taichung 404, Taiwan
    Management Office for Health Data, China Medical University Hospital, Taichung 404, Taiwan
    Department of Food Nutrition and Health Biotechnology, Asia University, Taichung 413, Taiwan)

  • Cheng-Li Lin

    (Management Office for Health Data, China Medical University Hospital, Taichung 404, Taiwan)

  • Kuen-Lin Wu

    (Division of Colorectal Surgery, Department of Surgery, Kaohsiung Chang-Gung Memorial Hospital and Chang-Gung University College of Medicine, Kaohsiung 833, Taiwan)

  • Kuen-Bao Chen

    (Department of Anesthesiology, China Medical University Hospital, China Medical University, Taichung 404, Taiwan
    Department of Anesthesiology, College of Medicine, China Medical University, Taichung 404, Taiwan)

Abstract

Colorectal cancer (CRC) is a common disease and one of the leading causes of cancer deaths worldwide. This retrospective cohort study evaluated the risk of developing CRC in people with hemorrhoids. Using Taiwan’s National Health Insurance Research Database, we established three sets of retrospective study cohorts with and without hemorrhoids. The first set of cohorts were matched by sex and age, the second set of cohorts were matched by propensity score without including colonoscopies, and the third set of cohorts were matched by propensity score with colonoscopies, colorectal adenomas, and appendectomies included. In the second set of cohorts, 36,864 persons with hemorrhoids that were diagnosed from 2000 to 2010 and a comparison cohort, with the same size and matched by propensity score, were established and followed up to the end of 2011 to assess the incidence and Cox proportional regression-measured hazard ratio (HR) of CRC. The overall incidence rate of CRC was 2.39 times greater in the hemorrhoid cohort than it was in the comparison cohort (1.29 vs. 0.54 per 1000 person-years), with a multivariable model measured adjusted HR of 2.18 (95% CI = 1.78–2.67) after controlling for sex, age, and comorbidity. Further analysis on the CRC incidence rates among colorectal sites revealed higher incidence rates at the rectum and sigmoid than at other sites, with adjusted HRs 2.20 (95% CI = 1.48–3.28) and 1.79 (95% CI = 1.06–3.02), respectively. The overall incidence rates of both cohorts were similar in the first and second sets of cohorts, whereas the rate was lower in the third set of hemorrhoid cohorts than in the respective comparison cohorts, probably because of overmatching. Our findings suggest that patients with hemorrhoids were at an elevated risk of developing CRC. Colonoscopy may be strongly suggested for identifying CRC among those with hemorrhoids, especially if they have received a positive fecal occult blood test result.

Suggested Citation

  • En-Bo Wu & Fung-Chang Sung & Cheng-Li Lin & Kuen-Lin Wu & Kuen-Bao Chen, 2021. "Colorectal Cancer Risk in Patients with Hemorrhoids: A 10-Year Population-Based Retrospective Cohort Study," IJERPH, MDPI, vol. 18(16), pages 1-10, August.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:16:p:8655-:d:615513
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/16/8655/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/16/8655/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Sergei I. Grivennikov & Kepeng Wang & Daniel Mucida & C. Andrew Stewart & Bernd Schnabl & Dominik Jauch & Koji Taniguchi & Guann-Yi Yu & Christoph H. Österreicher & Kenneth E. Hung & Christian Datz & , 2012. "Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth," Nature, Nature, vol. 491(7423), pages 254-258, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:16:p:8655-:d:615513. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.